Results 111 to 120 of about 280,401 (218)

Prevalence of Graves ophthalmopathy among patients with thyroid disease

Philippine Journal of Ophthalmology, 2010
Objective: This study determined the prevalence of Graves ophthalmopathy among thyroid-disease patients at a tertiary government hospital. Methods: Patients with thyroid disease seen at a tertiary hospital from February to September 2007 were enrolled.
Erwin D. Palisoc, MD, Evelyn S. Morabe, MD, Paulo Ma. N. Pagkatipunan, MD   +2 more
doaj  

Long-term follow-up of seven patients with ophthalmopathy not associated with thyroid autoimmunity: heterogeneity of autoimmune ophthalmopathy

Clinical Ophthalmology, 2012
Tom McCorquodale,1 Hooshang Lahooti,1 Bamini Gopinath,2 Jack R Wall11Department of Medicine, Nepean Clinical School, the University of Sydney, Penrith, NSW, Australia; 2Centre for Vision Research, the University of Sydney, Westmead Hospital, Westmead ...
McCorquodale T, Lahooti H, Gopinath B, Wall JR   +3 more
doaj  

UEG Week 2025 Poster Presentations

United European Gastroenterology Journal, Volume 13, Issue S8, Page S803-S1476, October 2025.
wiley   +1 more source

TEMPORAL RELATIONSHIP BETWEEN THE ONSET OF THYROID DERMOPATHY AND GRAVES' OPHTHALMOPATHY [PDF]

Acta Medica Iranica, 1993
Pretibial myxedema is an uncommon manifestation of Graves' disease and because of its rarity, information regarding its natural course and its relationship with other manifestations of Graves' disease is not sufficient."nWe reviewed 150 ...
Mohammad Pajhouhi
doaj  

Steroid Treatment Focused Management of Graves’ Ophthalmopathy

Acta Medica Bulgarica
Graves' disease (GD) is an autoimmune disease that affects the thyroid and the eyes. Graves' ophthalmopathy (GO), an autoimmune disease, usually appears 18 months after GD diagnosis.
Condeng Y. H., Umar H., Aman A. M., Rasyid H., Bakri S., Iskandar H.   +5 more
doaj   +1 more source

An in vitro model for thyroid autoimmunity [PDF]

, 1987
AM McGregor, BM Balfour, EM Allen, H Asamer, HR Harach, J Furszyfer, JE Fradkin, KW Wenzel, M Londei, N Bagchi, R Vollweider, T Hafanusa, TC Evans   +12 more
core   +1 more source

Síndrome metabólico [PDF]

, 2015
El síndrome metabólico es un conjunto de factores de riesgo, que requieren la presencia de obesidad de predominio central, dislipemia, hipertensión arterial y resistencia a la insulina, todos ellos, predictores de enfermedad cardiovascular y diabetes ...
Güemes-Hidalgo, M., Muñoz-Calvo, M. T.
core   +1 more source

ePoster

European Journal of Neurology, Volume 32, Issue S1, June 2025.
wiley   +1 more source

Update on the medical treatment of Graves’ ophthalmopathy

International Journal of General Medicine, 2009
Gregory J Griepentrog, James A GarrityDepartment of Ophthalmology, Mayo Clinic, Rochester, MN, USAPurpose: To review recent advances in the understanding of Graves’ ophthalmopathy (GO) pathogenesis as well as discuss current and future medical ...
Gregory J Griepentrog, James A Garrity
doaj  

Graves' ophthalmopathy

Swiss Medical Weekly, 2002
Swiss Medical Weekly
doaj   +1 more source